Cancer Research Cancer Research Funding Available  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bernard, D.
Right arrow Articles by Abbadie, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bernard, D.
Right arrow Articles by Abbadie, C.
[Cancer Research 61, 2656-2664, March 15, 2001]
© 2001 American Association for Cancer Research


Molecular Biology and Genetics

Antiproliferative and Antiapoptotic Effects of cRel May Occur within the Same Cells via the Up-Regulation of Manganese Superoxide Dismutase1

David Bernard, Brigitte Quatannens, Agnes Begue, Bernard Vandenbunder and Corinne Abbadie2

EP 560 [D. B., B. V., C. A.] and UMR 8526 [B. Q., A. B.], Centre National de la Recherche Scientifique/Institut Pasteur de Lille/Université Lille 2, Institut de Biologie de Lille, 59021 Lille Cedex, France

Rel/nuclear factor {kappa}B transcription factors were shown to have either pro- or antiapoptotic as well as pro- or antiproliferative functions, and it is often assumed that the outcome of their activation depends on the cell type or cellular context. Inconsistent with this assumption, we show here that cRel is able in one cell type to inhibit proliferation, protect against apoptosis induced by tumor necrosis factor {alpha} (TNF-{alpha}) + cycloheximide (CHX), and increase the basal rate of apoptosis. Both the effects of proliferation inhibition and protection against TNF-{alpha} + CHX-induced apoptosis are massive and occur in the same cells. Using reverse transcription-PCR, Western blot and immunofluorescence, and transactivation assays, we found that the manganese superoxide dismutase (MnSOD), an enzyme that converts O-2 in H2O2, is up-regulated by cRel through a {kappa}B site in intron 2. Inhibition of MnSOD induction by antisense oligonucleotides and overexpression of MnSOD respectively reverts and mimics both the antiproliferative and antiapoptotic effects of cRel, suggesting that they both occur via the induction of this gene. On one hand, MnSOD could improve the efficiency of cRel-overexpressing cells in eliminating toxic O-2 produced on TNF-{alpha} treatment, explaining why they escape TNF-{alpha}-induced apoptosis. On the other hand, cRel-overexpressing cells should accumulate H2O2. We present evidence linking this H2O2 accumulation to the proliferation arrest induced by cRel. Therefore, different effects on proliferation and apoptosis could arise from the induction of MnSOD and thus coexist in cRel-overexpressing cells.




This article has been cited by other articles:


Home page
IOVSHome page
W. Fan and N. G. F. Cooper
Glutamate-Induced NF{kappa}B Activation in the Retina
Invest. Ophthalmol. Vis. Sci., February 1, 2009; 50(2): 917 - 925.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-B. Lim, T. J. Park, and I. K. Lim
B Cell Translocation Gene 2 Enhances Susceptibility of HeLa Cells to Doxorubicin-induced Oxidative Damage
J. Biol. Chem., November 28, 2008; 283(48): 33110 - 33118.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Hrdlickova, J. Nehyba, A. S. Liss, and H. R. Bose Jr.
Mechanism of Telomerase Activation by v-Rel and Its Contribution to Transformation
J. Virol., January 1, 2006; 80(1): 281 - 295.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Papa, F. Zazzeroni, C. G. Pham, C. Bubici, and G. Franzoso
Linking JNK signaling to NF-{kappa}B: a key to survival
J. Cell Sci., October 15, 2004; 117(22): 5197 - 5208.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Bernard, K. Gosselin, D. Monte, C. Vercamer, F. Bouali, A. Pourtier, B. Vandenbunder, and C. Abbadie
Involvement of Rel/Nuclear Factor-{kappa}B Transcription Factors in Keratinocyte Senescence
Cancer Res., January 15, 2004; 64(2): 472 - 481.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Pizzi, F. Goffi, F. Boroni, M. Benarese, S. E. Perkins, H.-C. Liou, and P. Spano
Opposing Roles for NF-kappa B/Rel Factors p65 and c-Rel in the Modulation of Neuron Survival Elicited by Glutamate and Interleukin-1beta
J. Biol. Chem., May 31, 2002; 277(23): 20717 - 20723.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Bernard, B. Quatannens, B. Vandenbunder, and C. Abbadie
Rel/NF-kappa B Transcription Factors Protect against Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis by Up-regulating the TRAIL Decoy Receptor DcR1
J. Biol. Chem., July 13, 2001; 276(29): 27322 - 27328.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.